Pharmaceutical

Lilly and EVA Pharma to expand baricitinib access in Africa

Eli Lilly and EVA Pharma have formed a partnership to increase the availability of baricitinib in 49 African countries by 2030.

Sep 6, 2024 - 04:00
Lilly and EVA Pharma to expand baricitinib access in Africa
Eli Lilly and EVA Pharma have formed a partnership to increase the availability of baricitinib in 49 African countries by 2030.
Read the original article

Tags:

Previous Article

ArsenalBio secures $325m to develop cell therapy programmes

Next Article

Phase 2/3 of Athira Trial for Alzheimer’s Fails

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Pint Pharma announces Orladeyo approval in Mexico for HAE prevention

Pint Pharma announces Orladeyo approval in Mexico for H...

May 15, 2024

STAT+: European regulators tout their accomplishments against pharma’s anticompetitive practices

STAT+: European regulators tout their accomplishments a...

Jan 30, 2024

STAT+: Pharmalittle: FDA to furlough one-fifth of staff if government shuts down; FDA cites ‘grossly deficient’ data for ALS drug

STAT+: Pharmalittle: FDA to furlough one-fifth of staff...

Sep 26, 2023